Reuters News

Episode 0

Novartis Raises Full Year Outlook

0
N/A
out of 10
User Rating
0 votes

EPISODE REVIEWS
By TV.com Users

Write A Review

Episode Summary

EDIT
Novartis Raises Full Year Outlook
AIRED:
Swiss drug maker Novartis has raised its full-year outlook for 2013 . It's in response to delays to a generic competitor for its blockbuster blood pressure pill Diovan. A copycat version of the drug has so far failed to be approved by U.S. regulators. The delay has bought Novartis time after losing its U.S. patent protection on Diovan last year. But it's only short term. Next year is when the impact will hit. Underlying sales and operating income rose 8 and 18 percent respectively.moreless
Sunday
No results found.
Monday
No results found.
Tuesday
No results found.

Episode Discussion

Join the discussion of this episode Episode Discussion

Trivia, Notes, Quotes and Allusions

See All Trivia, Notes, Quotes and Allusions Trivia & Quotes

Season 0 Episodes

See All
 
Daily Digit: Hot Sales ...
 
Daily Digit: Battle Ove...
 
Retail Sales Unexpected...
 
Floods Hammer Southern ...
 
"TransWall" Brings New ...
 
Turkey's Tunnel Links E...
 
Rabobank's $1bln LIBOR ...
 
WHO Official Says "Risk...
 
Karlie Kloss Hits Sao P...
 
Will UK Bond Tempt Musl...
 
Jude Law: Acting Is a '...
 
Government Funding Cuts...
 
Daily Digit: Nokia Shar...
 
Government Funding Cuts...
 
U.N.'S Brahimi Meets wi...
 
Clean Up Batters Europe...
 
Costa Concordia Skipper...
 
Costa Concordia Skipper...
 
Tiananmen Crash 'Was At...
 
Mideast Prisoner Release
 
Why Chinese Aren't Big ...
 
India's Rate Hikes: Roo...
 
Chile Jails Four Over G...
 
Nuclear 'Action Not Wor...
 
Ford, Kingsley Hit 'End...
 
Inquiry Over Baby in Ca...
more